A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
Clinical trial NCT07075484 · COMPLETED
Trial details
- NCT number
- NCT07075484
- Sponsor
- China Immunotech (Beijing) Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2025-12-30
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.